WITHDRAWN: Chemoimmunotherapy versus chemotherapy for metastatic malignant melanoma.

CONCLUSIONS: We failed to find any clear evidence that the addition of immunotherapy to chemotherapy increases survival of people with metastatic melanoma. Further use of combined immunotherapy and chemotherapy should only be done in the context of clinical trials. PMID: 29409139 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29409139?dopt=Abstract

Source: Cochrane Database of Systematic Reviews - February 6, 2018 Category: General Medicine Authors: Sasse AD, Sasse EC, Clark LG, Clark OAC Tags: Cochrane Database Syst Rev Source Type: research